Semlali, A., Almutairi, M., Reddy Parine, N., Al Amri, A., Almeer, R., Alanazi, M. S., & Rouabhia, M. (2019). Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk. Mol Genet Genomic Med.
Παραπομπή Chicago StyleSemlali, Abdelhabib, Mikhlid Almutairi, Narasimha Reddy Parine, Abdullah Al Amri, Rafa Almeer, Mohammad S. Alanazi, και Mahmoud Rouabhia. "Expression and Allele Frequencies of Thymic Stromal Lymphopoietin Are a Key Factor of Breast Cancer Risk." Mol Genet Genomic Med 2019.
Παραπομπή MLASemlali, Abdelhabib, et al. "Expression and Allele Frequencies of Thymic Stromal Lymphopoietin Are a Key Factor of Breast Cancer Risk." Mol Genet Genomic Med 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.